Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by Biofinderon May 22, 2019 8:22am

132 Views

Post# 29763015

The board’s anger is aimed in the wrong direction imo

It’s the FDA that is to blame. The FDA is one of the most corrupt departments in the U.S. Government imo. The FDA routinely approves drugs that will kill you or permanently injure you for life, yet, the FDA wouldn’t approve the drug Ryplazim that has a 100% safety and efficiency record. IMO aim your energies at the real villain in this story, the FDA. This was all political hit job imo. Big Pharma has been one of the legs that run the U.S. Government imvho.

Bullboard Posts

Canadian artificial intelligence ETFs